Sarajuuri Anne, Lönnqvist Tuula, Mildh Leena, Rajantie Irmeli, Eronen Marianne, Mattila Ilkka, Jokinen Eero
Division of Neurology, Department of Paediatric and Adolescent Medicine, Helsinki University Central Hospital, Helsinki, Finland.
J Thorac Cardiovasc Surg. 2009 Jan;137(1):139-45, 145.e1-2. doi: 10.1016/j.jtcvs.2008.06.025. Epub 2008 Jul 24.
Despite recent advances in the treatment of children with univentricular heart, their neurodevelopmental outcome remains a major concern.
This prospective follow-up study evaluated the neurodevelopmental outcome of 23 patients with hypoplastic left heart syndrome, 14 with other forms of univentricular heart, and 46 healthy control subjects at a median age of 12.2 months. The Griffiths Developmental Scale and Alberta Infant Motor Scale served for developmental evaluation.
The mean Griffiths developmental quotient of children with hypoplastic left heart syndrome was significantly less (91.6) than that of control children (106.8, P < .001). Patients with univentricular heart scored significantly lower than control subjects only in the gross motor domain (P = .001) but not in overall development (100.6). Alberta Infant Motor Scale scores were significantly lower in children with hypoplastic left heart syndrome (37.5, P < .001) and univentricular heart (43.5, P = .011) than in control subjects (53.3). In linear regression a diagnosis of hypoplastic left heart syndrome (P = .016), a clinical history of seizure (P = .002), and the highest plasma lactate level after the bidirectional Glenn operation (P = .045) were significantly associated with the developmental quotient.
At age 1 year, the level of development of children with univentricular heart was significantly lower than for control subjects only in motor skills, whereas children with hypoplastic left heart syndrome had a more widespread developmental delay. The diagnosis, a clinical seizure history, and increased plasma lactate levels after the bidirectional Glenn operation emerged as risk factors.
尽管近期在单心室心脏病患儿的治疗方面取得了进展,但其神经发育结局仍是一个主要关注点。
这项前瞻性随访研究评估了23例左心发育不全综合征患儿、14例其他形式单心室心脏病患儿以及46例健康对照受试者在12.2个月龄时的神经发育结局。使用格里菲斯发育量表和艾伯塔婴儿运动量表进行发育评估。
左心发育不全综合征患儿的平均格里菲斯发育商(91.6)显著低于对照儿童(106.8,P <.001)。单心室心脏病患者仅在大运动领域的得分显著低于对照受试者(P =.001),但在总体发育方面(100.6)并非如此。左心发育不全综合征患儿(37.5,P <.001)和单心室心脏病患儿(43.5,P =.011)的艾伯塔婴儿运动量表得分显著低于对照受试者(53.3)。在线性回归中,左心发育不全综合征的诊断(P =.016)、癫痫临床病史(P =.002)以及双向格林手术后的最高血浆乳酸水平(P =.045)与发育商显著相关。
1岁时,单心室心脏病患儿的发育水平仅在运动技能方面显著低于对照受试者,而左心发育不全综合征患儿的发育延迟更为广泛。诊断、癫痫临床病史以及双向格林手术后血浆乳酸水平升高成为风险因素。